Case Studies – The Catapult Network

Browse Catapults

Case Studies from across the Catapults

Search

Themes (Reset)

Medicines Discovery

alt=

How do we supercharge and sustain skills in UK Life Sciences?

Medicines Discovery Catapult is reshaping drug discovery for patient benefit by transforming great UK science into better treatments through partnership. The life sciences industry is critical to the UK’s health, wealth, and resilience. Attracting, recruiting, training, and retaining a skilled workforce is key to ongoing success in this critical sector.

Medicines Discovery

How do we supercharge and sustain skills in UK Life Sciences?

Medicines Discovery Catapult is reshaping drug discovery for patient benefit by transforming great UK science into better treatments through partnership. The life sciences industry is critical to the UK’s health, wealth, and resilience. Attracting, recruiting, training, and retaining a skilled workforce is key to ongoing success in this critical sector.

Medicines Discovery

Bolstering the North West’s position as a life science powerhouse

Medicines Discovery Catapult is driving regional growth in the North West of England, supporting the region’s fast-growing and increasingly significant life science industry.

Medicines Discovery

Launch of a drug discovery consortium to address the unmet therapeutic needs of people living with mental health conditions

The Psychiatry Consortium is a £4 million international collaboration between seven global pharmaceutical companies and two leading medical research charities, convened and managed by Medicines Discovery Catapult, to support high-value drug discovery projects that address the unmet therapeutic needs of people living with mental health conditions, including psychiatric symptoms associated with dementia.

Medicines Discovery

alt=

Highlighting the role of women in science and innovation

By championing innovative life science technology and new approaches, Medicines Discovery Catapult is supporting UK innovators to succeed. Medicines Discovery Catapult recognises that diversity in the workforce underpins the creative and innovative thinking essential for success in this sector.

Medicines Discovery

alt=

International biobank provides database for cancer researchers worldwide

Medicines Discovery Catapult collaborated with Manchester University to create a sustainable model for a biorepository providing a critical data for researchers investigating patient side-effects from radiotherapy.

Medicines Discovery

alt=

Innovative treatments for a longer healthy, independent life

Figures show that we are spending more of our lives in poor health. In response, a national network is bringing together scientific expertise from across the UK to shed new light on the ageing process and help us stay healthy for longer.

Medicines Discovery

Innovative treatments for a longer healthy, independent life

Figures show that we are spending more of our lives in poor health. In response, a national network is bringing together scientific expertise from across the UK to shed new light on the ageing process and help us stay healthy for longer.

Medicines Discovery

alt=

Mobilising national high scale COVID-19 testing

In March 2020, the UK government announced the launch of a national testing effort to support the UK’s fight against coronavirus via the establishment of a network of high-scale testing laboratories, known as “Lighthouse Labs”.

Medicines Discovery

Mobilising national high scale COVID-19 testing

In March 2020, the UK government announced the launch of a national testing effort to support the UK’s fight against coronavirus via the establishment of a network of high-scale testing laboratories, known as “Lighthouse Labs”.

Medicines Discovery

test tubes

Developing new treatments to prevent thrombosis

LUNAC Therapeutics, a UK based drug discovery company, together with the Medicines Discovery Catapult and the University of Leeds, are working on the development of an innovative first-in-class anticoagulant treatment drug with minimal bleeding risk.

Medicines Discovery

Discovery Services platform boosts UK life sciences R&D and international competitiveness

The Medicines Discovery Catapult Virtual R&D Discovery Services platform helps match UK SMEs to access medicines and drug discovery services and state-of-the-art equipment, enabling deeper market penetration and access to a wider network of customers.

Page 1 of 1